好像不是很好的消息
NASDAQ Grants Cell Therapeutics 180-Day Extension to Regain Compliance With Minimum Bid Price Rule
Cell Therapeutics Inc., with shares of stock that haven’t traded above $1 since March 22, has not met the NASDAQ stock exchange’s $1-a-share minimum bid price.
The Seattle biotech was warned back in May by the stock exchange and was given until Nov. 1 to achieve compliance. On Wednesday, NASDAQ gave the company another 180 days to achieve compliance with the minimum-share-price requirement.
On Wednesday, shares in Cell Therapeutics (NASDAQ: CTIC) opened at 39 cents per share.
Cell Therapeutics Inc., with shares of stock that haven’t traded above $1 since March 22, has not met the NASDAQ stock exchange’s $1-a-share minimum bid price.
The Seattle biotech was warned back in May by the stock exchange and was given until Nov. 1 to achieve compliance. On Wednesday, NASDAQ gave the company another 180 days to achieve compliance with the minimum-share-price requirement.
On Wednesday, shares in Cell Therapeutics (NASDAQ: CTIC) opened at 39 cents per share.
|